Grzegorz Król, Ph.D. is a Director at Knowledge•Action•Change, the sister company to KAC Communications which runs GFN. Social psychologist & IT specialist, author of publications on psychology, data analysis and harm reduction. Since 2003 Grzegorz manages international projects in the area of public health, drugs and tobacco harm reduction. Between 2012 and 2018, he was lecturer at the Faculty of Management and MBA School, University of Warsaw. Since 2016, member of the European Network for Research Evaluation in the Social Sciences and the Humanities (ENRESSH), part of the COST Action: European Cooperation in Science and Technology. Co-founder of a harm reduction knowledge hub at harmreduction.eu

Andrzej Fal graduated from the Medical University and the University of Economics in Warsaw. He followed post-doctoral studies at Johns Hopkins University, USA and has also been trained at the National Heart and Lung Institute, in London. Prof. Fal is head of the Department of Allergy, Lung Diseases and Internal Diseases, National Institute of Medicine in Warsaw. He has published over 350 papers on allergy, pulmonology, public health, and is the founder and Editor in Chief of “Public Health Forum”. Prof. Fal is a member of the Board of Directors of the GLIMMER Initiative, and on behalf of the Polish Ministry of Science was a member of the Board of the Polish-American Fulbright Commission. He was also a member of the European Medicinal Agency of the Committee for Advanced Therapies. Since November 2014 he has been the President of the Polish Society of Public Health.

Michelle Minton is a senior policy analyst at the Reason Foundation specializing in consumer policy, covering regulatory issues around gambling, tobacco harm reduction, cannabis legalization, alcohol, and nutrition. The author of numerous studies, her analyses have been published and cited in the New York Times, the Wall Street Journal and USA Today and peer-reviewed journals, and Michelle regularly appears in news media to discuss the unintended effects of laws designed to save adults from their own choices which not only conflicts with the principle of individual liberty, but often the goals of public health. She holds a BA from Johns Hopkins and an MSc from the University of New England.

Martin Cullip is a former company director and International Fellow of the Taxpayers Protection Alliance, who has written and blogged on free market and lifestyle consumer issues for over a decade. As a user of e-cigarettes and other safer nicotine products, he is a particularly passionate consumer advocate for all forms of tobacco harm reduction and has a keen interest in the rapidly-evolving nicotine market and the politics surrounding it. Martin is a former Chair of UK educational charity The New Nicotine Alliance and has taken part in parliamentary evidence sessions and consumer, industry, and political events on the subject domestically and internationally.

Ian Jones is the R&D Scientific Product Assessment Center Vice President at Japan Tobacco International (JTI), based in Kanagawa Japan, and is responsible for leading JTI R&D’s fundamental chemical, material and biological research activities. Ian joined JTI in 2006 from the University of Bath, UK, where he was a lecturer in Developmental Neuroscience at the Department of Biology and Biochemistry. Since then, Ian has held several regulatory science-related roles in the company, including Reduced-Risk Science Vice President and R&D Principal Scientist. Ian has a particular interest in the harm reduction potential of oral tobacco- and nicotine-containing products and has participated in several cross-industry activities to develop, for example, harmonized terminology and product standards for smokeless tobacco products. Ian holds a PhD in cell physiology, completed at Imperial College, London (1995).

Emmanuel Mwape, a Zambian filmmaker born in Lusaka in 1992, is renowned for his impactful storytelling on tobacco harm reduction. He's an alumnus of the Tobacco Harm Reduction Scholarship program and a Kevin Molloy Fellow. Experienced in both fiction and non-fiction, Mwape employs film to spark conversations and effect social change. His award-winning works include "Saving Chalo" and "Helping Chalo," which delve into the complexities of tobacco harm reduction. Mwape's films not only captivate audiences but also serve as catalysts for advocacy, prompting reflection and dialogue. Through his dedication to amplifying marginalized voices, Mwape has become a luminary in the Zambian film industry, utilizing his craft to shed light on pressing social issues and inspire action worldwide.

Professor Marewa Glover is one of New Zealand’s leading tobacco control researchers. She has worked on reducing smoking-related harm for 31 years. She is recognized internationally for her advocacy on tobacco harm reduction; and locally was a Finalist in the New Zealander of the Year Supreme Award in 2019 recognising her contribution to reducing smoking in NZ. In 2018, Dr Glover was appointed Tobacco Section Editor for the Harm Reduction Journal. In that year she also established the Centre of Research Excellence: Indigenous Sovereignty & Smoking an international program of research aimed at reducing smoking-related harms among Indigenous peoples globally. The Centre’s research was funded with grants from the Foundation for a Smoke-Free World, Inc. (“FSFW”), a US nonprofit 501(c)(3) private foundation.

Martin Cullip is a former company director and International Fellow of the Taxpayers Protection Alliance, who has written and blogged on free market and lifestyle consumer issues for over a decade. As a user of e-cigarettes and other safer nicotine products, he is a particularly passionate consumer advocate for all forms of tobacco harm reduction and has a keen interest in the rapidly-evolving nicotine market and the politics surrounding it. Martin is a former Chair of UK educational charity The New Nicotine Alliance and has taken part in parliamentary evidence sessions and consumer, industry, and political events on the subject domestically and internationally.

Summer Hanna, PhD serves as Head of Scientific Regulation on behalf of BAT. She is responsible for Group-wide scientific engagement to drive the awareness and acceptance of Tobacco Harm Reduction and the development of science-based regulatory approaches for reduced risk products globally. Dr. Hanna has held a variety of US and Global roles across Scientific Research & Development and Regulatory Affairs. She most recently led the development of the cannabinoid discovery science programme as part of BAT’s Beyond Nicotine strategy. Previously, Summer led teams within Reynolds’ FDA Submissions & Engagement team focused on their smokeless tobacco portfolio, along with previous roles in Analytical Research. Before joining Reynolds American in 2011, Hanna received her PhD in Analytical Chemistry from Wake Forest University. She currently serves as treasurer to the US Technical Advisory Group for ISO/ TC 126.

Emmanuel Mwape, a Zambian filmmaker born in Lusaka in 1992, is renowned for his impactful storytelling on tobacco harm reduction. He's an alumnus of the Tobacco Harm Reduction Scholarship program and a Kevin Molloy Fellow. Experienced in both fiction and non-fiction, Mwape employs film to spark conversations and effect social change. His award-winning works include "Saving Chalo" and "Helping Chalo," which delve into the complexities of tobacco harm reduction. Mwape's films not only captivate audiences but also serve as catalysts for advocacy, prompting reflection and dialogue. Through his dedication to amplifying marginalized voices, Mwape has become a luminary in the Zambian film industry, utilizing his craft to shed light on pressing social issues and inspire action worldwide.

Described by Rolling Stone as "the point man" for drug policy reform efforts and “the real drug czar,” Ethan Nadelmann, JD, PhD is widely regarded as the outstanding proponent of drug policy reform in the United States and abroad. After teaching politics and public affairs at Princeton University (1987-1994), he founded and directed first The Lindesmith Center (1994-2000) and then the Drug Policy Alliance (2000-2017). He also co-founded the Open Society Institute’s International Harm Reduction Development program. Ethan has published extensively and spoken publicly in roughly forty states and forty countries. His TED Talk has over two million views. Ethan and his colleagues were at the forefront of dozens of successful campaigns to legalize marijuana, reduce the incarceration of drug law offenders, advance harm reduction approaches to drug use and addiction, and otherwise promote alternatives to the war on drugs. Ethan hosts the leading podcast about all things drugs: PSYCHOACTIVE. And he has become increasingly engaged in the debate over tobacco harm reduction.

Lindsey Stroud is a Senior Fellow at the Taxpayers Protection Alliance, which provides data and analysis to inform and assist policymakers when addressing consumer products. Her main areas of focus are goods including alcohol, tobacco and vapor products, and regulatory policies that affect adult access, including harm reduction, technology, innovation, antitrust and privacy. At The Heartland Institute, she authored policy resources and hosted a podcast on tobacco harm reduction, and has also worked for state lawmakers in two states. Creator and manager of Tobacco Harm Reduction 101 (thr101.org), she holds senior positions at the American Vapor Manufacturers Association and the Independent Women's Forum.

Professor Gerry Stimson is a leading advocate for tobacco harm reduction and an Emeritus Professor at Imperial College London. A public health social scientist, with over 50 years’ experience of research and advocacy, he was one of the founders of drugs harm reduction in the 1990s, helping to develop and evaluate harm reduction in the UK as a response to HIV/AIDS. Gerry has advised the UK Government, WHO, UNAIDS, UNODC, the World Bank and numerous governments around the world on issues relating to drugs, HIV infection and AIDS, and alcohol. He has also published over 220 scientific publications and several books. Currently, Gerry is advisor to Knowledge•Action•Change, and is involved in the FSFW-funded Global Tobacco Harm Reduction Initiative. He is also a co-founder of the Global Forum on Nicotine, which has been delivered by KAC Communications since 2014.

Dr McGovern qualified in Medicine in 1995 from Trinity College Dublin and has worked as a GP specialising in the treatment of substance misuse since the implementation of the methadone treatment protocol in 1998. He is Medical Director of the Priority Medical Clinic, a private addiction treatment programme located in South County Dublin. In January 2022 he was appointed Clinical Lead for the HSE Addiction Services in Louth Meath & The Midlands. Dr McGovern holds a Master’s degree in Clinical and Public Health Aspects of Addiction from The National Addiction Centre, King’s College London, is a Diplomate of the International Society of Addiction Medicine (ISAM) and holds a Professional Diploma in Clinical Leadership from the Royal College of Surgeons in Ireland. He is also one of the first members of the International Doctors for Healthy Drug Policies (IDHDP),an international group of medical addiction experts aiming to promote sensible drug policies. Dr McGovern is also a member of the Irish Chapter of the New Nicotine Alliance.

Ian is an independent consultant with expertise in regulatory and scientific aspects of nicotine and tobacco products. His consulting work encompasses clinical and behavioural studies of tobacco and nicotine products for regulatory submissions in the US and Europe, and he has a wealth of experience of both consumer goods and medicinal licensing submissions. His 16 years working in the Tobacco Harm Reduction arena has included roles as Senior Director of Clinical and Regulatory Affairs EMEA with JUUL Labs, Director of Tobacco Research with Celerion, and Principal Scientist and Head of Clinical Research at British American Tobacco. As well as his consulting, Ian is a Scientific Advisory Board Member with Qnovia, a medtech startup seeking authorisation for a novel NRT in the UK and the US, and is also an Independent Non-Exec Director with Advanced Inhalation Rituals (AIR), a global shisha manufacturer.

Professor Marewa Glover is one of New Zealand’s leading tobacco control researchers. She has worked on reducing smoking-related harm for 31 years. She is recognized internationally for her advocacy on tobacco harm reduction; and locally was a Finalist in the New Zealander of the Year Supreme Award in 2019 recognising her contribution to reducing smoking in NZ. In 2018, Dr Glover was appointed Tobacco Section Editor for the Harm Reduction Journal. In that year she also established the Centre of Research Excellence: Indigenous Sovereignty & Smoking an international program of research aimed at reducing smoking-related harms among Indigenous peoples globally. The Centre’s research was funded with grants from the Foundation for a Smoke-Free World, Inc. (“FSFW”), a US nonprofit 501(c)(3) private foundation.

Emmanuel Mwape, a Zambian filmmaker born in Lusaka in 1992, is renowned for his impactful storytelling on tobacco harm reduction. He's an alumnus of the Tobacco Harm Reduction Scholarship program and a Kevin Molloy Fellow. Experienced in both fiction and non-fiction, Mwape employs film to spark conversations and effect social change. His award-winning works include "Saving Chalo" and "Helping Chalo," which delve into the complexities of tobacco harm reduction. Mwape's films not only captivate audiences but also serve as catalysts for advocacy, prompting reflection and dialogue. Through his dedication to amplifying marginalized voices, Mwape has become a luminary in the Zambian film industry, utilizing his craft to shed light on pressing social issues and inspire action worldwide.

Heneage Mitchell, commonly known as ‘H’, has been resident in Asia for over 40 years. He spent most of those decades working in regional media, including as managing editor and co-publisher of Tobacco Asia, a trade publication reporting on the regional tobacco industry. In 2012, he established factasia, an independent, not-for-profit, consumer-oriented regional advocacy for rational debate about – and sensible regulation of – the rights of adult citizens throughout the Asia-Pacific region to choose to use tobacco or other nicotine-related products. Heneage smoked for over 45 years before switching to vaping in 2016, since when he has never touched a cigarette.

Lindsey Stroud is a Senior Fellow at the Taxpayers Protection Alliance, which provides data and analysis to inform and assist policymakers when addressing consumer products. Her main areas of focus are goods including alcohol, tobacco and vapor products, and regulatory policies that affect adult access, including harm reduction, technology, innovation, antitrust and privacy. At The Heartland Institute, she authored policy resources and hosted a podcast on tobacco harm reduction, and has also worked for state lawmakers in two states. Creator and manager of Tobacco Harm Reduction 101 (thr101.org), she holds senior positions at the American Vapor Manufacturers Association and the Independent Women's Forum.

Jeffrey Zamora is President of Asovape Costa Rica, President of ARDT Iberoamerica, Social Media Director and Audiovisual Producer for INNCO, recipient of the Enhanced KAC THRSP Scholarship with a project on a documentary series called #Safer, and Project Leader for the Veritas Study of ECLAT (Spin-off of the University of Catania, Italy). Jeffrey Zamora has worked in Social Media and Marketing with NGOs, Governmental Entities, and Commercial Brands. Jeffrey Zamora es Presidente de Asovape Costa Rica (organización de consumidores adultos Pro Reducción de Daños para personas que no quieren o pueden dejar de fumar), Presidente de ARDT Iberoamérica, Director de Redes Sociales y Productor Audiovisual para INNCO, recipiente de la Enhanced Scholarship de KAC THRSP con un proyecto sobre una serie documental llamada #Safer, y Líder de Proyecto para el estudio Veritas de ECLAT (Spin off de la Universidad de Catania, Italia). Jeffrey Zamora ha estado trabajando en Redes Sociales y Marketing con ONGs, Entidades Gubernamentales y Marcas Comerciales.

PhD. in Cell Biology and Genetics from the Autonomous University of Madrid, she is the founder, coordinator, and/or scientific advisor of different organisations related to Smoking Harm Reduction, such as the Spanish Medical Platform for Smoking Harm Reduction, composed of about 30 doctors, professors, and health professionals, as well as the Spanish Association of Personal Vapourisers Users (ANESVAP). She is the organiser of THR SUMMIT SPAIN, the first scientific congress on Smoking Harm Reduction in Spain, now in its second edition. She has attended or participated as a speaker in several congresses related to THR. He also collaborates actively with users and scientific organisations in Latin America.

Doctorada en Biología Celular y Genética por la Universidad Autónoma de Madrid, es fundadora, coordinadora y/o asesora científica de distintas organizaciones relacionadas con la Reducción de Daños por Tabaquismo, como la Plataforma Médica Española por la Reducción de Daños por Tabaquismo, compuesta por cerca de 30 médicos, catedráticos y profesionales sanitarios, así como de la Asociación Española de Usuarios de Vaporizadores Personales (ANESVAP). Esorganizadora del THR SUMMIT SPAIN, primer congreso científico sobre Reducción de Daños por Tabaquismo en España que ya va por su segunda edición. Ha asistido o participado como ponente en varios congresos relacionados con la THR. También colabora activamente con organizaciones de usuarios y científicos hermanas en Latinoamérica.

Dr. Diego Joaquín Verrastro - Medical specialist in general surgery - Emergentology
Spokesperson for Reldat

Tomás is a Mexican lawyer and teaches Corporation Law and Successions Law at Universidad Panamericana in Mexico City. An ex-smoker and vaper since 2016, he is co-founder of "Pro-Vapeo Mexico", a Mexican consumer association (registered in 2017), that advocates for tobacco harm reduction and non- combustible alternatives. He is a member of INNCO’s Board.

Medical Lieutenant-Colonel of the Military Health Corps. General Surgeon of the Surgery Service of the Hospital Central de la Defensa "Gómez Ulla" in Madrid. Specialist in Oncological Surgery. Associate Professor in the Department of Surgery at the Faculty of Medicine of the University of Alcalá de Henares. Doctor of Medicine, Rey Juan Carlos University, Madrid. Spokesperson for the Platform for Smoking Harm Reduction. Pioneering platform in Spain to eradicate smoking. Presenter and content director of the medicine channel on Youtube MedicinaClara, with more than 1.5M subscribers and more than 200M videos viewed. Medical director and content director of the medical portal www.medicosespecialistasen.com. Evaluator of the access to the Military Health Corps of the Ministry of Defence.

Teniente Coronel Médico del Cuerpo Militar de Sanidad. Cirujano General del Servicio de Cirugía del Hospital Central de la Defensa "Gómez Ulla" en Madrid. Especialista en Cirugía Oncológica. Profesor asociado al Departamento de Cirugía en la Facultad de Medicina de la Universidad de Alcalá de Henares. Doctor en Medicina por la Universidad Rey Juan Carlos de Madrid. Portavoz de la Plataforma para la Reducción del Daño por Tabaquismo. Plataforma pionera en España para erradicar el tabaquismo. Presentador y director de contenidos del canal de medicina en Youtube MedicinaClara, canal con más de 1,5M de suscriptores y más de 200M de vídeos vistos. Director médico y director de contenidos del portal médico www.medicosespecialistasen.com. Evaluador del acceso al Cuerpo Militar de Sanidad del Ministerio de Defensa.

Ángeles Muntadas-Prim chairs the Spanish Association Supporting Vapers (ANESVAP). Formed in 2014, ANESVAP is the only association

in Spain defending vapers’ rights. ANESVAP is also a founding member of INNCO, and she serves on INNCO’s Governing Board. She’s cofounder/organizer of the THR Summit Spain (2018), which gathered tobacco harm reduction experts from around the world. She has been

instrumental in promoting the Tobacco Harm Reduction Platform in Spain (2019) for doctors and scientists and in the creation of AHL

Provape, a network of organisations in Latin America focused on vaping and THR. She meets with various politicians, medical associations, and media and also attends various events and political rallies in order to ensure that consumers are represented.

Summer Hanna, PhD serves as Head of Scientific Regulation on behalf of BAT. She is responsible for Group-wide scientific engagement to drive the awareness and acceptance of Tobacco Harm Reduction and the development of science-based regulatory approaches for reduced risk products globally. Dr. Hanna has held a variety of US and Global roles across Scientific Research & Development and Regulatory Affairs. She most recently led the development of the cannabinoid discovery science programme as part of BAT’s Beyond Nicotine strategy. Previously, Summer led teams within Reynolds’ FDA Submissions & Engagement team focused on their smokeless tobacco portfolio, along with previous roles in Analytical Research. Before joining Reynolds American in 2011, Hanna received her PhD in Analytical Chemistry from Wake Forest University. She currently serves as treasurer to the US Technical Advisory Group for ISO/ TC 126.

Emmanuel Mwape, a Zambian filmmaker born in Lusaka in 1992, is renowned for his impactful storytelling on tobacco harm reduction. He's an alumnus of the Tobacco Harm Reduction Scholarship program and a Kevin Molloy Fellow. Experienced in both fiction and non-fiction, Mwape employs film to spark conversations and effect social change. His award-winning works include "Saving Chalo" and "Helping Chalo," which delve into the complexities of tobacco harm reduction. Mwape's films not only captivate audiences but also serve as catalysts for advocacy, prompting reflection and dialogue. Through his dedication to amplifying marginalized voices, Mwape has become a luminary in the Zambian film industry, utilizing his craft to shed light on pressing social issues and inspire action worldwide.

David Sweanor is an adjunct professor, Faculty of Law, and chair of the advisory board of the Centre for Health Law, Policy & Ethics at the University of Ottawa and has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked globally, and with numerous groups, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization and played a key role in achieving many global precedents in tobacco policy. He currently focuses much of his tobacco and nicotine related efforts on risk reduction strategies.

Stefanie Miller is vice president of external affairs at Juul Labs Inc. Prior to joining Juul Labs, Miller spent more than a decade as a Wall Street analyst with expertise in political and policy risk to financial markets and companies therein, including the nicotine and tobacco industries. Miller began her career working for a former U.S. senator from her home state of Nebraska. She received her Master of Business Administration degree from Georgetown University and her Bachelor of Arts degree in economics and political science from the University of Nebraska.

Konstantinos Farsalinos, MD, MPH, is a physician and a research associate at the University of Patras and the University of West Attica in Greece. His field of expertise is Public Health. He has been conducting laboratory, clinical and epidemiological research on smoking, tobacco harm reduction and nicotine products as principal investigator since 2011. He authored the first systematic review on e-cigarette safety/risk profile, published in 2014. Additionally, he has performed research and published studies on heated tobacco products. His findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union in 2014. As of early 2024, he has published more than 100 studies and articles in international peer-reviewed scientific journals, mostly about smoking, tobacco harm reduction and alternative-to-smoking nicotine products. He has presented in more than 80 international conferences and he was the handling editor and author of a book titled "Analytical assessment of e-cigarettes", published by Elsevier in 2017. In November 2020, he was declared a Highly Cited Researcher 2019 by the Web of Science, a list of researchers (6200 scientists out of 9 million examined) with the highest impact in global science in 21 scientific fields in the past decade. During the COVID-19 pandemic, he has published 10 peer-reviewed articles and several pre-prints about COVID-19, including the association between smoking, nicotine and COVID-19.

Emmanuel Mwape, a Zambian filmmaker born in Lusaka in 1992, is renowned for his impactful storytelling on tobacco harm reduction. He's an alumnus of the Tobacco Harm Reduction Scholarship program and a Kevin Molloy Fellow. Experienced in both fiction and non-fiction, Mwape employs film to spark conversations and effect social change. His award-winning works include "Saving Chalo" and "Helping Chalo," which delve into the complexities of tobacco harm reduction. Mwape's films not only captivate audiences but also serve as catalysts for advocacy, prompting reflection and dialogue. Through his dedication to amplifying marginalized voices, Mwape has become a luminary in the Zambian film industry, utilizing his craft to shed light on pressing social issues and inspire action worldwide.

David Sweanor is an adjunct professor, Faculty of Law, and chair of the advisory board of the Centre for Health Law, Policy & Ethics at the University of Ottawa and has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked globally, and with numerous groups, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization and played a key role in achieving many global precedents in tobacco policy. He currently focuses much of his tobacco and nicotine related efforts on risk reduction strategies.

Vivien Azer has 20 years of experience in Equity Research covering Consumer Staples. Most recently, she served as Managing Director and senior research analyst at TD Cowen, specializing in the beverages, tobacco, and cannabis sectors. Vivien is the first senior Wall Street analyst to cover the emerging cannabis sector, resulting in notable global press coverage across media outlets such as CNBC, The Wall Street Journal, The Economist, Barron’s, and Forbes. Vivien’s coverage of the tobacco and cannabis sectors has earned her industry accolades, including a spot on Institutional Investor’s All-America Research Team on several occasions. In 2022, Vivien was selected as one of the most influential names in cannabis on Forbes’ “The Cannabis 42.0” list. She was also named to MJBiz Daily’s list of “20 Women to Watch in 2019” and selected by Business Insider as a “Rising Star of Marijuana Investing.”

Dr. Arielle Selya is a behavioral scientist at PinneyAssociates, Inc. and consults to Juul Labs, Inc. (JLI) on tobacco harm reduction. Her primary expertise is tobacco use behavior among youth and adults. She also individually consults to the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) on e-cigarette use behavioral research. Prior to joining Pinney Associates, she spent a decade in academia studying adolescent substance use and addiction. She previously held a faculty position at Sanford Research, where she led initiatives to translate population-health research projects into clinical implementation, and to make electronic medical records available on demand. She also served as an Assistant Professor at the University of North Dakota in the Master of Public Health program. Arielle has over 60 publications to her credit in behavioral science and methodology.

Dr Roberto A Sussman (PhD University of London) is a full time senior researcher and lecturer at the Institute for Nuclear Sciences of the National University of Mexico. His main research areas are General Relativity and Cosmology, but he has conducted research in other areas of Physics, including peer reviewed publications on e-cigarette aerosols. He is also the founder and Director of Pro-Vapeo Mexico, an association representing Mexican consumers of noncombustible nicotine products and is a member of INNCO. He is actively advocating for an appropriate regulation of Tobacco Harm Reduction products in Mexico. He directs and supervises the effort to spread scientific information on these products, as well as advising consumers on how to counter the governmental misinformation and prejudice about them that is rampant throughout Latin America.

Will is the founding editor-in-chief of Filter, an online magazine that launched in 2018 to cover drug use, drug policy and human rights through a harm reduction lens. He's also the executive director of The Influence Foundation, the New York nonprofit behind Filter. His past work in the drugs and human rights spaces has included founding and/or editing a number of other publications, and consulting for various organizations. Originally from England, he now lives in Vermont.

Professor Marewa Glover is one of New Zealand’s leading tobacco control researchers. She has worked on reducing smoking-related harm for 31 years. She is recognized internationally for her advocacy on tobacco harm reduction; and locally was a Finalist in the New Zealander of the Year Supreme Award in 2019 recognising her contribution to reducing smoking in NZ. In 2018, Dr Glover was appointed Tobacco Section Editor for the Harm Reduction Journal. In that year she also established the Centre of Research Excellence: Indigenous Sovereignty & Smoking an international program of research aimed at reducing smoking-related harms among Indigenous peoples globally. The Centre’s research was funded with grants from the Foundation for a Smoke-Free World, Inc. (“FSFW”), a US nonprofit 501(c)(3) private foundation.

Christopher Snowdon is the head of lifestyle economics at the Institute of Economic Affairs. He is a regular contributor to the Spectator, The Critic and Spiked and often appears on TV and radio discussing lifestyle regulation, prohibition and policy-based evidence. He is the editor of the Nanny State Index and the author of six books: ‘Polemics’ (2020), ‘Killjoys’ (2017), ‘Selfishness, Greed and Capitalism’ (2015), ‘The Art of Suppression' (2011), ‘The Spirit Level Delusion’ (2010) and ‘Velvet Glove, Iron Fist’ (2009). Snowdon has also written more than a twenty reports for the Institute of Economic Affairs including ‘Drinking, Fast and Slow’, ‘Joint Venture’, ‘Cheap as Chips’, ‘Sock Puppets’ and ‘Death and Taxes’. He is also co-host of the Last Orders podcast.